UNITED STATES

 SECURITIES AND EXCHANGE COMMISSION 

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of Earliest Event Reported):   July 19, 2012

 

STAAR Surgical Company
__________________________________________

 

(Exact name of registrant as specified in its charter)

 

     
Delaware 0-11634 95-3797439
(State or other jurisdiction (Commission (I.R.S. Employer
of incorporation) File Number) Identification No.)
     
1911 Walker Ave, Monrovia, California   91016
(Address of principal executive offices)   (Zip Code)

 

     
Registrant’s telephone number, including area code:   626-303-7902

 

Not Applicable

______________________________________________

 

Former name or former address, if changed since last report

  

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 

 

Item 2.02 Results of Operations and Financial Condition

 

On July 19, 2012, STAAR Surgical Company issued a Press Release providing its selected preliminary financial results for the second quarter ended June 29, 2012. A copy of the Press Release is furnished as Exhibit 99.1 to this Current Report and is incorporated herein by this reference.

 

The financial information furnished in this Current Report for the quarter ended June 29, 2012 is selected preliminary information and remains subject to review by STAAR Surgical Company’s independent registered public accountants. STAAR Surgical Company will release its financial results for the quarter on August 1, 2012. Financial information for the quarter, which STAAR Surgical Company will release on August 1, 2012 or report in its Quarterly Report on Form 10-Q, may differ.

 

The information furnished herewith pursuant to Item 2.02 of this Current Report, including Exhibit 99.1, shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. The information in this Current Report shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date of this Current Report, regardless of any general incorporation language in the filing.

 

Item 9.01 Financial Statements and Exhibits

 

(d) Exhibits

  

Exhibit No. Description
99.1 Press Release, dated July 19, 2012, of STAAR Surgical Company.

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

STAAR Surgical Company 
 
July 19, 2012 By: /s/ Barry G. Caldwell
    Barry G. Caldwell
    President and Chief Executive Officer

 

 
 

 

  Exhibit Index
   
99.1 Press Release, dated July 19, 2012, of STAAR Surgical Company.